This relationship points to possible involvement of NGAL in the broader metabolic disturbances associated with CKD, including mineral metabolism, which is often a challenge in managing CKD due to its implications for bone health and cardiovascular stability. This evidence concerns the gene LCN2 and chronic kidney disease.